Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.12
-0.20 (-2.15%)
Feb 27, 2026, 11:11 AM EST - Market open
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.43 billion as of February 27, 2026. Its market cap has increased by 10.96% in one year.
Market Cap
1.43B
Enterprise Value
1.10B
1-Year Change
10.96%
Ranking
Category
Stock Price
$9.12
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has decreased from $1.53B to $1.43B, a decrease of -6.55%. That is a compound annual growth rate of -1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 1.40B | 66.31% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.50B |
| uniQure | 1.48B |
| Trevi Therapeutics | 1.48B |
| EyePoint | 1.47B |
| Palvella Therapeutics | 1.47B |
| Capricor Therapeutics | 1.46B |
| Savara | 1.45B |
| Zenas BioPharma | 1.44B |